Bacterial factors and immune pathogenesis in Helicobacter pylori infection

Gut

Volumn 43, Issue SUPPL. 1, 1998, Pages

  Shimoyama, T ^b   Crabtree, J E ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; CYTOTOXIN; GENE PRODUCT;

BACTERIAL GENE; BACTERIAL VIRULENCE; COMPLEMENT ACTIVATION; CONFERENCE PAPER; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HOST RESISTANCE; LEUKOCYTE ACTIVATION; NONHUMAN; PEPTIC ULCER; PRIORITY JOURNAL; STOMACH MUCOSA LESION; T LYMPHOCYTE ACTIVATION;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNITY, MUCOSAL; LYMPHOCYTE ACTIVATION; NEUTROPHIL ACTIVATION; VIRULENCE;

EID: 0031816886     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Leunk RD, Johnson PT, David BC, et al. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 1988;26:93-9.
2. Cover TL, Blaser MJ. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem 1992;267:10570-5.
3. Figura N, Guglielmetti P, Rossolini A, et al. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol 1989;27:225-6.
4. de Bernard M, Papini E, de Fiippis V, et al. Low pH activates the vacuolating toxin of Helicobacter pylori, which becomes acid and pepsin resistant. J Biol Chem 1995;270:23937-40.
5. Atherton JC, Cao P, Peek RM, et al. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. J Biol Chem 1995;270:17771-7.
6. Atherton JC, Peek RM, Tham KT, et al. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 1997;112:92-9.
7. Shimoyama T, Yoshimura T, Mikami T, et al. Evaluation of Helicobacter pylori vacA genotype in Japanese patients with gastric cancer. J Clin Pathol (in press).
8. Ito Y, Azuma T, Ito S, et al. Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. J Clin Microbiol 1997;35:1710-14.
9. Covacci A, Censini S, Bugnoli M, et al. Molecular characterisation at the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993;30:5791-5.
10. Crabtree JE, Farmery SM, Lindley IJD, et al. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cells. J Clin. Pathol 1994;47:945-50.
11. Crabtree JE, Covacci A, Farmery SM, et al. Helicobacter pylori and-induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J Clin Pathol 1995;48:41-5.
12. Sharma SA, Tummuru MKR, Miller GG, et al. Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun 1995;63:1681-7.
13. Yamaoka Y, Kita M, Kodama T, et al. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 1996;110:1744-52.
14. Peek RM, Miller GG, Tham KT, et al. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest 1995;73:760-70.
15. Crabtree JE, Taylor JD, Wyatt JI, et al. Mucosal IgA recognition of Helicobacter pylori 120kDa protein, peptic ulceration and gastric pathology. Lancet 1991;338:332-5.
16. Weel JFL, van der Hulst RWM, Gerrits Y, et al. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis 1996;173:1171-5.
17. Beales ILP, Crabtree JE, Scunes D, et al. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1996;8:645-9.
18. Kuipers EJ, Pérez-Pérez GI, Meuwissen SGM, et al. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995;87:1777-80.
19. Parsonnet J, Friedman GD, Orentreich N, et al. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997;40:297-301.
20. Blaser MJ, Pérez-Pérez GI, Kleanthous H, et al. Infection of strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55:2111-15.
21. Crabtree JE, Wyatt JI, Sobala GM, et al. Systemic and mucosal humoral responses to in gastric cancer. Gut 1993;34:1339-43.
22. Censini S, Lange C, Xiang Z, et al. cag, a pathogenesity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci 1996;93:14648-53.
23. Akopyants NS, Clifton SW, Kersulyte D, et al. Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol 1998;28:37-54.
24. Crabtree JE, Xiang Z, Lindley IJD, et al. Induction of interleukin-8 secretion from gastric epithelial calls by cagA negative isogenic mutant of Helicobacter pylori. J Clin Pathol 1995;48:967-9.
25. Crabtree JE, Kersulyte D, Hernandez V, et al. Helicobacter pylori induction of IL-8 synthesis in gastric epithelial cells depends on genes throughout the cag pathogenisity island [abstract]. Gut 1997;40(suppl 1):A69.
26. Tummuru MKR, Sharma SA, Blaser MJ. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol 1995;18:867-76.
27. Moran AP. The role of lipopolysaccharide in Helicobacter pylori pathogenesis. Aliment Pharmacol Ther 1996;10(suppl 1):39-50.